The invention provides compounds capable of treating against hepatitis infections, particularly hepatitis B viral infections. Compounds of the invention are nucleic acid-based and preferably comprise 2, 3, 4, 5 or 6 nucleoside units.

 
Web www.patentalert.com

< Aspirin-triggered lipid mediators

< Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1

> Methods and reagents for the treatment of inflammatory disorders

> Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use
~ 00604